Microbiology · Year 2 · from Microbiology
Case 1: MRSA Skin and Soft Tissue Infection
Presentation
A 28-year-old otherwise healthy man presents to urgent care with a painful "boil" on his right thigh that has been worsening over 5 days. He first noticed a small red bump that he thought was a spider bite. He is an amateur wrestler and practices 3-4 times per week. He has no significant medical history and takes no medications.
Physical examination reveals a 4 cm indurated, erythematous, fluctuant mass on the anterior right thigh with central purulent drainage. There is surrounding cellulitis extending 2 cm beyond the abscess border. He is afebrile and hemodynamically stable. No inguinal lymphadenopathy is appreciated.
Gram stain of the purulent drainage shows gram-positive cocci in clusters.
Clinical Image
Gram stain demonstrating gram-positive cocci in grape-like clusters - characteristic appearance of Staphylococcus aureus.
Image Source: Lecture image - staphylococcal morphology
Questions
- What is the most likely causative organism, and what epidemiological factors in this patient's history support this diagnosis?
- The culture result confirms methicillin-resistant Staphylococcus aureus (MRSA). What is the genetic and molecular basis of methicillin resistance?
- What is the most important treatment intervention for this patient's abscess?
- A toxin called Panton-Valentine leukocidin (PVL) is commonly associated with community-acquired MRSA strains. What is its mechanism and clinical significance?
Answers
- Most likely organism and epidemiology: Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is the most likely causative organism. Supporting epidemiological factors include:
- Contact sport participation: Wrestlers have significantly elevated MRSA rates due to skin-to-skin contact, shared equipment, and skin abrasions
- Healthy young adult: CA-MRSA typically affects healthy individuals without healthcare exposure, unlike healthcare-associated MRSA (HA-MRSA)
- Skin abscess presentation: CA-MRSA classically presents as skin and soft tissue infections, particularly abscesses, furuncles, and carbuncles
- "Spider bite" history: Patients frequently initially attribute CA-MRSA skin infections to spider bites
The Gram stain showing gram-positive cocci in grape-like clusters is pathognomonic for staphylococci.
- Genetic basis of methicillin resistance:
- mecA gene: MRSA carries the mecA gene located on the staphylococcal cassette chromosome mec (SCCmec)
- PBP2a production: mecA encodes penicillin-binding protein 2a (PBP2a), an altered transpeptidase enzyme
- Reduced β-lactam affinity: PBP2a has very low affinity for all β-lactam antibiotics (penicillins, cephalosporins, carbapenems), allowing cell wall synthesis to continue despite antibiotic presence
- Cross-resistance: Methicillin resistance confers resistance to ALL β-lactam antibiotics except for the newer agents ceftaroline and ceftobiprole, which have affinity for PBP2a
- Laboratory detection: mecA can be detected by cefoxitin disk diffusion (cefoxitin is a better inducer of mecA expression than oxacillin) or by PCR for the mecA gene
- Most important treatment intervention: Incision and drainage (I&D) is the cornerstone of treatment for skin abscesses and is often curative alone for uncomplicated abscesses <5 cm without surrounding cellulitis.
For this patient with a 4 cm abscess AND surrounding cellulitis, treatment should include:
- Incision and drainage: Essential - antibiotics without I&D often fail
- Antibiotics covering MRSA: Options for outpatient management include:
- Trimethoprim-sulfamethoxazole (TMP-SMX) - most commonly used
- Doxycycline
- Clindamycin (check local resistance patterns; inducible resistance may occur)
- Cultures should be sent to confirm susceptibility
- Duration: 5-10 days depending on response
- Panton-Valentine leukocidin (PVL):
- Mechanism: PVL is a bicomponent pore-forming toxin consisting of two secreted proteins (LukS-PV and LukF-PV) that oligomerize on neutrophil membranes to form pores
- Target specificity: PVL specifically targets and destroys neutrophils and macrophages
- Clinical significance:
- Associated with 77% of CA-MRSA strains (especially USA300 clone) vs. <5% of HA-MRSA
- Correlates with severe necrotizing skin infections
- Associated with necrotizing pneumonia (often post-influenza)
- Contributes to recurrent furunculosis
- Pathogenic contribution: By destroying the primary phagocytic defense against S. aureus, PVL promotes bacterial survival and enhances tissue destruction